-
Le 19 novembre 2020Le COVID-19 doit redéfinir la sécurité sanitaire mondiale
Il a récemment été annoncé que plusieurs nouveaux vaccins contre le coronavirus ont obtenu d’excellents résultats. Ceci nous laisse espérer que la vie redeviendra normale et que le bilan catastrophique de décès cessera de s’alourdir – de bonnes nouve... -
Le 19 novembre 2020Why drug-resistant tuberculosis poses a major risk to global health security
Par Dr. Eliud Wandwalo, Head of Tuberculosis Department
Drug-resistant tuberculosis (DR-TB) is a form of antimicrobial resistance that is difficult and costly to treat. It is caused by TB bacteria that are resistant to at least one of the first-line existing TB medications, resulting in fewer treatment op... -
Le 29 septembre 2020
COVID-19 Rapid Tests: A Milestone in Fight Against the Pandemic - By Peter Sands, Executive Director of the Global Fund
-
Le 21 septembre 2020
COVID-19 is a Turning Point for Infectious Diseases - By Peter Sands, Executive Director of the Global Fund
-
Le 14 septembre 2020
Fragile Progress in the Fight Against HIV, Tuberculosis and Malaria (in French) With Françoise Vanni, Head of External Relations and Communications at the Global Fund
-
Le 03 septembre 2020
Conversation with Francoise Vanni (in Italian) With Françoise Vanni, Head of External Relations and Communications at the Global Fund
-
-
Le 13 juillet 2020
The "Huge Amount at Stake" for HIV Progress With Peter Sands, Executive Director of the Global Fund
-
Le 13 juillet 2020
HIV, Tuberculosis, and Malaria: How can the Impact of COVID-19 be Minimised? - By Peter Sands, Executive Director of the Global Fund
-